HIV-1

ViiV Healthcare seeks USFDA approval to expand Cabenuva use for HIV-1 infected adults
Pharmaceutical Business Review
Thu, 02/25/21 - 09:50 am
ViiV Healthcare
FDA
Cabenuva
HIV-1
ViiV Healthcare gets FDA expanded approval for HIV-1 drug Dovato
Pharmaceutical Business Review
Fri, 08/7/20 - 10:40 am
ViiV Healthcare
FDA
HIV
Dovato
HIV-1
ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment
Pharmaceutical Business Review
Fri, 11/22/19 - 10:02 am
HIV
NIH
ViiV Healthcare
HIV-1
drug discovery
ViiV Submits NDA for Once-Per-Month HIV Injectable
BioSpace
Mon, 04/29/19 - 08:54 pm
ViiV Healthcare
FDA
HIV
HIV-1
cabotegravir
rilpivirine
Gilead Sciences’ Biktarvy shows high efficacy in HIV-1 study
Pharmaceutical Business Review
Thu, 10/4/18 - 09:42 am
Gilead Sciences
Biktarvy
HIV-1
HIV
ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment
Yahoo
Tue, 08/16/16 - 11:14 am
ViiV Healthcare
HIV
Dolutegravir
HIV-1
lamivudine
Gilead's HIV-1 Drug Wins Approval in Europe
Motley Fool
Tue, 11/19/13 - 07:37 am
HIV-1
Gilead Sciences
Vitekta
Europe
ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1
Yahoo
Fri, 09/13/13 - 08:30 am
Dolutegravir
ViiV Healthcare
Darunavir
HIV-1
ING114915